β <sub>2</sub> ‐Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β <sub>2</sub> ‐adrenoceptor with possible implications for the treatment of asthma-Reference-Cited by-同舟云学术

β ₂ ‐Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β ₂ ‐adrenoceptor with possible implications for the treatment of asthma

Published:2022-07-19 Issue:19 Volume:179 Page:4692-4708
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

De Pascali Francesco¹,Ippolito Michael¹,Wolfe Emily²,Komolov Konstantin E.¹,Hopfinger Nathan¹,Lemenze Douglas²,Kim Nicholas²,Armen Roger S.³,An Steven S.²,Scott Charles P.¹,Benovic Jeffrey L.¹

Affiliation:

1. Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College Thomas Jefferson University Philadelphia Pennsylvania USA

2. Rutgers Institute for Translational Medicine and Science, New Brunswick, New Jersey and Department of Pharmacology, Rutgers‐Robert Wood Johnson Medical School The State University of New Jersey Piscataway New Jersey USA

3. Department of Pharmaceutical Sciences, College of Pharmacy Thomas Jefferson University Philadelphia Pennsylvania USA

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15900

Reference66 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes